Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807350 · ClinicalTrials.gov registry record · NA
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A NA study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 386
- Enrollment target
NCT02807350 is a NA study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 386 participants.
The verdict
NCT02807350, a NA study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 386 participants
- Enrollment target
Study Summary
The main objectives of this randomized trial comparing overminus lens treatment to non-overminus (spectacles without overminus or spectacles with plano lenses) are to determine: * The long-term on-treatment effect of overminus treatment on distance intermittent exotropia (IXT) control score. * The off-treatment effect of overminus treatment on distance IXT control score (following weaning and 3 months off treatment).
Interventions
- DEVICE Overminus treatment
- DEVICE Non-overminus treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02807350
The ClinicalTrials.gov registry entry for NCT02807350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 386 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Overminus treatment is the first listed.
NCT02807350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02807350 about?
NCT02807350 is a clinical study titled "Trial of Overminus Spectacle Therapy for Intermittent Exotropia". The main objectives of this randomized trial comparing overminus lens treatment to non-overminus (spectacles without overminus or spectacles with plano lenses) are to determine: * The long-term on-treatment effect of overminus treatment on distance intermittent exotropia (IXT) control score. * The ...
What is the current status of trial NCT02807350?
This trial is currently completed. It is a NA study. The enrollment target is 386 participants. The study started on 2017-01-16. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT02807350?
The interventions under investigation include: Overminus treatment (DEVICE), Non-overminus treatment (DEVICE).
Who is sponsoring clinical trial NCT02807350?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.